All Stories

  1. Gender disparities in heart failure diagnosis and management: under the radar
  2. Prediction of New Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction Using Artificial Intelligence and Machine Learning Algorithms
  3. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  4. How type 2 diabetes and COPD affect each other: a review of mechanisms and patient management
  5. COPD Trial Evidence Comes from a Narrow Slice of the World: A Population Representativeness Analysis.
  6. Kounis Syndrome Features in Special Populations
  7. Impact of older age on prognosis in hypersensitivity pneumonitis: A systematic review and meta‑analysis
  8. COPD and kidney disease: not so far apart?
  9. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  10. A deep dive into atrial fibrillation in chronic obstructive pulmonary disease
  11. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  12. Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
  13. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
  14. Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis
  15. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  16. Patients with sickle cell disease and asthma have a higher risk for acute chest syndrome: A systematic review and meta‑analysis of observational studies
  17. Impact of urogenital and enterocolitic infections on the onset and evolution of ankylosing spondylitis and psoriatic arthritis
  18. Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions
  19. The Hidden Burden of COMISA: Clinical Implications and Treatment Challenges
  20. Burden of ophthalmologic disorders in obstructive sleep apnea
  21. Diagnostic and management controversies in ANCA-associated interstitial lung diseases
  22. Fungal allergy - features of molecular diagnosis
  23. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease
  24. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  25. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  26. Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review)
  27. The impact of comorbidities on chronic obstructive pulmonary disease
  28. Tuberculosis in new cases: the impact of HIV status on clinical manifestations
  29. Comparative analysis of clinical characteristics of gout patients
  30. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
  31. Anti-reflux therapy and mortality in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a systematic review and meta-analysis
  32. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders—Part II
  33. Diurnal variation in spirometry parameters of patients with chronic obstructive pulmonary disease: A systematic review and meta‑analysis
  34. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  35. Metabolic storm in psoriatic arthritis: a cardiovascular time bomb?
  36. Diagnostic tools in respiratory medicine (Review)
  37. COPD and Depression—The Vicious Mental Cycle
  38. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  39. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  40. Challenges of Pediatric Tuberculosis Under Current Conditions
  41. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  42. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  43. Assessment of comorbidities in COPD patients by chest HRCT
  44. Endobronchial foreign bodies in pediatric work – history and clinical signs suggestive of diagnosis
  45. Sarcoidosis and cancer - a diagnostic dilema
  46. Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
  47. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  48. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  49. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  50. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  51. Editorial: Treatment of comorbidities of asthma and its safety
  52. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  53. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  54. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  55. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  56. Promising treatment biomarkers in asthma
  57. Complications of tracheobronchial foreign body aspiration in children
  58. Phenotypes in adult patients with bronchiectasis: a cluster analysis
  59. The Burden of Comorbidities in Obstructive Sleep Apnea
  60. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  61. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  62. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  63. Updates in screening for tuberculosis. Review of guidelines
  64. Diagnostic challenges of a rare disease with an unusual presentation
  65. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  66. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  67. COPD and Diabetes Mellitus: Down the Rabbit Hole
  68. Scientists Against War: A Plea to World Leaders for Better Governance
  69. COPD and comorbidities in the Republic of Moldova
  70. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  71. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  72. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  73. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  74. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  75. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  76. Asthma-COPD Overlap: A more Simplistic Approach
  77. Chronic obstructive disease and comorbidities (literature review)
  78. Current Approaches to Asthma In 2021
  79. A rare case of intrathymic epidermoid cyst
  80. Asthma and stroke: a narrative review
  81. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  82. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  83. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  84. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  85. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  86. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  87. Current Approaches to COPD in 2019
  88. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  89. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  90. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  91. Identification of clinical phenotypes using cluster analyses in COPD patients
  92. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  93. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  94. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  95. COPD and Stroke
  96. Health-related quality of life in different phenotypes of COPD
  97. Assessment of health-related quality of life in different phenotypes of COPD
  98. Bode index in different phenotypes of COPD
  99. To sleep, or not to sleep?
  100. ACOS: current evidence and future research directions
  101. Phenotyping Before Starting Treatment in COPD?
  102. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  103. Exercise-Induced Pulmonary Edema in Athletes
  104. Editorial: "COPD: More than a Moving Target!"
  105. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  106. Prevalence and burden of comorbidities in COPD
  107. Meet Our Assistant Editor
  108. Overview of the translocation of rupestrian ferruginous fields of Capão Xavier mine to the Serra do Rola Moça State Park, Minas Gerais – Brazil
  109. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  110. Health-Related Quality of Life in Patients with COPD
  111. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  112. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  113. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  114. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  115. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  116. Management of Stable COPD: An Update
  117. Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report
  118. Defining COPD
  119. Imaging for diagnosis and management of tuberculosis